Ramsay Health Care stock reports 19.3 percent NPAT growth on FY26 results

Published on 10/07/2026 at 06:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Ramsay Health Care stock posted AUD 1.16 billion in FY26 underlying EBIT, up 11.5 percent year over year. The dividend reached AUD 0.91 per share.

Ramsay, AU000000RHC8, Illustration mit AI erstellt.

Ramsay Health Care stock was last at AUD 54.84 on the ASX on October 7, 2026 at 3:13 p.m. AEDT, up 0.26 percent for the session and 2.04 percent below its 52-week high of AUD 55.98. The company entered the new fiscal year after FY26 underlying net profit after tax rose 19.3 percent to AUD 364.1 million, according to TheBull on September 10, 2026.

FY26 profit growth leads the story

Ramsay's FY26 underlying earnings before interest and tax increased 11.8 percent to AUD 1.16 billion, while group revenue reached AUD 18.6 billion. The operating improvement was broader than the top line, with the underlying EBIT margin rising 30 basis points to 6.2 percent.

The result covered the 12 months ended June 30, 2026, and followed a 13.7 percent share-price gain on August 27, the day the full-year figures were released. The full-year dividend increased 13.8 percent to AUD 0.91 per share, giving income-focused shareholders a larger distribution after the earnings recovery.

Valuation now tests the recovery

The earnings improvement has lifted the market value of the healthcare operator to AUD 12.6 billion as of October 7, 2026. The stock's 52-week range is AUD 30.39 to AUD 55.98, placing the latest price near the upper end of that span.

According to MarketScreener on September 8, 2026, Ord Minnett raised its target to AUD 48.00 from AUD 46.30 but retained a Lighten rating. The broker cited a normalized Australian EBIT margin of 9.6 percent in FY26 and a 17.1 percent margin on incremental revenue in the second half.

Analysts see a lower average target

MarketScreener lists a Hold consensus from 15 analysts, with four Buy ratings, 10 Holds and one Sell. The average target is AUD 51.93, while the published target range runs from AUD 41.90 to AUD 66.00.

That spread gives the stock a clear investor debate: operating earnings are improving, but the share price has moved ahead of the average published target. The next checkpoint is the execution of the earnings recovery rather than the headline growth alone, particularly as margin gains and patient activity carry more weight in the valuation.

Ramsay stock stays near its yearly high

Ramsay Health Care was last at AUD 54.84 on the ASX on October 7, 2026, with 238,091 shares traded during the session. The day range was AUD 54.48 to AUD 55.07, keeping the price close to its 52-week high while the FY26 figures remain the central valuation reference.